ABEO EBITDA Growth
Abeona Therapeutics Inc · EBITDA Growth
ABEO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-189.16%period ending
ABEO TTM EBITDA YoY % (63.12% → -189.16%)
Year-over-year change
High-resolution chart · PNG
ABEO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -189.1612% | |
| 298.8033% | |
| 238.793% | |
| 238.3448% | |
| 268.433% | |
| 48.9538% | |
| -11.9612% | |
| -41.8385% | |
| -10.2904% | |
| -104.1936% | |
| -24.4788% | |
| -7.3827% | |
| -8.5066% | |
| 19.8031% | |
| 8.44% | |
| 5.2065% | |
| 10.8667% | |
| -2.6866% | |
| -4.363% | |
| -6.0946% | |
| 15.9056% | |
| 32.4219% | |
| 37.0911% | |
| 41.761% | |
| 27.8584% | |
| -0.3451% | |
| -18.7577% | |
| -56.5019% | |
| -104.8954% | |
| -98.7409% | |
| -114.1889% | |
| -85.9267% | |
| -61.1784% | |
| -54.4729% | |
| -26.2713% | |
| -51.8327% | |
| -11.0961% | |
| -18.4063% | |
| -50.6335% | |
| -34.6352% | |
| -161.7882% | |
| -8.9026% | |
| 6.1491% | |
| 20.5427% | |
| 45.9845% | |
| -1,942.9434% | |
| -359.7147% | |
| -7,469.9761% | |
| 1.749% | |
| 103.1686% | |
| 115.8127% | |
| 100.8342% | |
| -18.782% | |
| -603.8205% | |
| -2,647.7635% | |
| -220.0026% | |
| -45.3346% | |
| 51.4019% | |
| 82.4578% | |
| -6.9097% | |
| 6.9523% | |
| 11.8713% | |
| 20.155% | |
| 18.7687% | |
| -0.7193% | |
| -1.6181% | |
| 46.3847% | |
| 50.4289% | |
| 44.4597% | |
| 42.0525% | |
| -307.9907% | |
| -1,985.5505% | |
| -1,502.7145% | |
| -618.5781% | |
| -328.6245% | |
| 45.1572% | |
| 139.8882% | |
| 155.6551% | |
| 131.42% | |
| 75.0079% | |
| 61.8063% | |
| 26.0455% | |
| 25.1156% | |
| 19.3663% | |
| 1.666% | |
| -1.173% | |
| -9.4053% | |
| -10.9861% | |
| 3.1508% | |
| 14.1984% | |
| 8.7222% | |
| 4.5131% | |
| -18.1477% | |
| -35.7294% | |
| -41.0667% | |
| -24.686% | |
| -17.724% | |
| -6.4762% | |
| -1.7918% | |
| -25.8642% |